feed,title,long_url,short_url
Investors,"Bristol Myers Squibb, Exelixis Granted FDA Priority Review For Kidney Cancer Treatment",https://www.investors.com/news/technology/bmy-stock-edges-higher-bristol-myers-squibb-kidney-cancer-drug-gets-fda-priority-review/,https://j.mp/2T9xhLk
